346 related articles for article (PubMed ID: 31582565)
1. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
[TBL] [Abstract][Full Text] [Related]
2. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin.
Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM
Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200
[TBL] [Abstract][Full Text] [Related]
3. Dilated cardiomyopathy myosin mutants have reduced force-generating capacity.
Ujfalusi Z; Vera CD; Mijailovich SM; Svicevic M; Yu EC; Kawana M; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
J Biol Chem; 2018 Jun; 293(23):9017-9029. PubMed ID: 29666183
[TBL] [Abstract][Full Text] [Related]
4. Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load.
Karabina A; Kazmierczak K; Szczesna-Cordary D; Moore JR
Arch Biochem Biophys; 2015 Aug; 580():14-21. PubMed ID: 26116789
[TBL] [Abstract][Full Text] [Related]
5. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of force-pCa relation in
Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
[TBL] [Abstract][Full Text] [Related]
7. Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy.
Kawana M; Sarkar SS; Sutton S; Ruppel KM; Spudich JA
Sci Adv; 2017 Feb; 3(2):e1601959. PubMed ID: 28246639
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
Roopnarine O; Leinwand LA
Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
[TBL] [Abstract][Full Text] [Related]
9. Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil.
Tang W; Unrath WC; Desetty R; Yengo CM
J Biol Chem; 2019 Nov; 294(46):17314-17325. PubMed ID: 31578282
[TBL] [Abstract][Full Text] [Related]
10. The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.
Bell KM; Kronert WA; Huang A; Bernstein SI; Swank DM
J Physiol; 2019 May; 597(9):2403-2420. PubMed ID: 30950055
[TBL] [Abstract][Full Text] [Related]
11. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
Toepfer CN; Garfinkel AC; Venturini G; Wakimoto H; Repetti G; Alamo L; Sharma A; Agarwal R; Ewoldt JK; Cloonan P; Letendre J; Lun M; Olivotto I; Colan S; Ashley E; Jacoby D; Michels M; Redwood CS; Watkins HC; Day SM; Staples JF; Padrón R; Chopra A; Ho CY; Chen CS; Pereira AC; Seidman JG; Seidman CE
Circulation; 2020 Mar; 141(10):828-842. PubMed ID: 31983222
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
[TBL] [Abstract][Full Text] [Related]
13. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
[TBL] [Abstract][Full Text] [Related]
15. β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.
Blankenburg R; Hackert K; Wurster S; Deenen R; Seidman JG; Seidman CE; Lohse MJ; Schmitt JP
Circ Res; 2014 Jul; 115(2):227-37. PubMed ID: 24829265
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
[TBL] [Abstract][Full Text] [Related]
17. Mavacamten decreases maximal force and Ca
Awinda PO; Watanabe M; Bishaw Y; Huckabee AM; Agonias KB; Kazmierczak K; Szczesna-Cordary D; Tanner BCW
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H881-H890. PubMed ID: 33337957
[TBL] [Abstract][Full Text] [Related]
18. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
Ramírez CD; Padrón R
Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
[TBL] [Abstract][Full Text] [Related]
19. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
[TBL] [Abstract][Full Text] [Related]
20. Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.
Sommese RF; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM
PLoS One; 2013; 8(12):e83403. PubMed ID: 24367593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
